BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18273571)

  • 1. [Between scylla and charybdis-bleeding and thromboembolism in cardiovascular medicine].
    Lüscher TF; Kucher N
    Herz; 2008 Feb; 33(1):1-3. PubMed ID: 18273571
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanical valve anticoagulation--between Scylla and Charybdis.
    Ståhle E
    Scand Cardiovasc J; 2001 Mar; 35(2):69-71. PubMed ID: 11405498
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monitoring of coagulation during treatment with direct oral anticoagulants].
    Kasper A; Lindhoff-Last E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
    [No Abstract]   [Full Text] [Related]  

  • 4. [Between Scylla and Charybdis].
    Brean A
    Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1322. PubMed ID: 19561655
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
    Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Para-spinal regional anesthesia and prevention of thromboembolism/anticoagulation. Recommendations of the German Society of Anesthesiology and Intensive Care Medicine, October 1997].
    Gogarten W; Van Aken H; Wulf H; Klose R; Vandermeulen E; Harenberg J
    Urologe A; 1998 May; 37(3):347-51. PubMed ID: 9646433
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of bleeding in patients undergoing oral anticoagulant therapy].
    Riess H
    Klin Monbl Augenheilkd; 2014 Apr; 231(4):e23-34; quiz e35-6. PubMed ID: 24771193
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral anticoagulants.
    McGlasson DL
    Clin Lab Sci; 2004; 17(2):107-12. PubMed ID: 15168892
    [No Abstract]   [Full Text] [Related]  

  • 9. Hazard--the anticoagulation bridge or just go transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):48-9. PubMed ID: 19089937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of old and new anticoagulants].
    Stämpfli SF; Asmis LM; Tanner FC
    Herz; 2008 Feb; 33(1):4-12. PubMed ID: 18273572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for long-term anticoagulant therapy].
    Koller M
    Schweiz Rundsch Med Prax; 1988 Mar; 77(13):343-6. PubMed ID: 3287553
    [No Abstract]   [Full Text] [Related]  

  • 13. Turning aptamers into anticoagulants.
    Famulok M
    Nat Biotechnol; 2004 Nov; 22(11):1373-4. PubMed ID: 15529158
    [No Abstract]   [Full Text] [Related]  

  • 14. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
    van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ
    Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry.
    Prandoni P; Trujillo-Santos J; Surico T; Dalla Valle F; Piccioli A; Monreal M;
    Haematologica; 2008 Sep; 93(9):1432-4. PubMed ID: 18757855
    [No Abstract]   [Full Text] [Related]  

  • 16. Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis?
    Boriani G; Diemberger I; Biffi M; Martignani C
    Chest; 2010 Nov; 138(5):1032-3. PubMed ID: 21051391
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations on bleeding and nonbleeding complications of vitamin K antagonists.
    Ansell J
    Clin Adv Hematol Oncol; 2007 Jul; 5(7):517-8, 554. PubMed ID: 17679924
    [No Abstract]   [Full Text] [Related]  

  • 18. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.
    Eikelboom JW; Quinlan DJ; O'Donnell M
    Circulation; 2009 Nov; 120(20):2006-11. PubMed ID: 19884469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombomodulin as a marker for bleeding complications during warfarin treatment.
    Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH
    Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of anticoagulant therapy for patients with venous thromboembolism.
    Garcia D
    Thromb Res; 2008; 123 Suppl 1():S62-4. PubMed ID: 18823648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.